Tanke Biosciences Corp (TNBI): Cost of Revenue

Annual figures by period end, from SEC filings.

Not updated since 2012-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

$18.62M
Year ended 2012-12-31
2010-12-31: $12.70M2011-12-31: $15.06M2012-12-31: $18.62M$18.62M
2010-12-31 Cost of Revenue (USD) 2012-12-31
Period endedCost of RevenueChange YoYSource filing
2012-12-31$18.62M+23.6%2013-04-15, From 2012-01-01
2011-12-31$15.06M+18.6%2013-04-15, From 2011-01-01
2010-12-31$12.70Mn/a2012-04-16, From 2010-01-01